JP2012506237A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506237A5
JP2012506237A5 JP2011531514A JP2011531514A JP2012506237A5 JP 2012506237 A5 JP2012506237 A5 JP 2012506237A5 JP 2011531514 A JP2011531514 A JP 2011531514A JP 2011531514 A JP2011531514 A JP 2011531514A JP 2012506237 A5 JP2012506237 A5 JP 2012506237A5
Authority
JP
Japan
Prior art keywords
lip1
seq
sequence number
sign
variable domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011531514A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506237A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/063655 external-priority patent/WO2010046337A2/en
Publication of JP2012506237A publication Critical patent/JP2012506237A/ja
Publication of JP2012506237A5 publication Critical patent/JP2012506237A5/ja
Pending legal-status Critical Current

Links

JP2011531514A 2008-10-21 2009-10-19 Dc−signに対する結合特異性をもつリガンド Pending JP2012506237A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10708508P 2008-10-21 2008-10-21
US61/107,085 2008-10-21
PCT/EP2009/063655 WO2010046337A2 (en) 2008-10-21 2009-10-19 Ligands that have binding specificity for dc-sign

Publications (2)

Publication Number Publication Date
JP2012506237A JP2012506237A (ja) 2012-03-15
JP2012506237A5 true JP2012506237A5 (enExample) 2012-11-22

Family

ID=42062429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011531514A Pending JP2012506237A (ja) 2008-10-21 2009-10-19 Dc−signに対する結合特異性をもつリガンド

Country Status (16)

Country Link
US (1) US20110257373A1 (enExample)
EP (1) EP2356149A2 (enExample)
JP (1) JP2012506237A (enExample)
KR (1) KR20110071139A (enExample)
CN (1) CN102257009A (enExample)
AR (1) AR073905A1 (enExample)
AU (1) AU2009306424A1 (enExample)
BR (1) BRPI0919714A2 (enExample)
CA (1) CA2740856A1 (enExample)
EA (1) EA201100488A1 (enExample)
IL (1) IL212086A0 (enExample)
MX (1) MX2011004244A (enExample)
TW (1) TW201019962A (enExample)
UY (1) UY32189A (enExample)
WO (1) WO2010046337A2 (enExample)
ZA (1) ZA201102763B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009306425B2 (en) * 2008-10-21 2013-09-12 Domantis Limited Composition for targeting dendritic cells
EP2793918B1 (en) * 2011-12-19 2019-09-11 The Rockefeller University Hdc-sign binding peptides
EP4392022A4 (en) * 2021-08-27 2025-11-12 Univ Georgia Targeted Nanoparticles and Their Uses in Infectious Disease
CN118184795B (zh) * 2022-12-13 2025-03-21 成都维瑾柏鳌生物医药科技有限公司 抗hiv-1的重组蛋白及其应用
CN120591214A (zh) * 2025-07-02 2025-09-05 山东第一医科大学第二附属医院 一种过表达dc-sign基因的重组arh77细胞系及其构建方法与应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU665440B2 (en) * 1992-06-05 1996-01-04 Dade Produktions Ag Rabbit single domain antibody and use thereof
EP2284192A3 (en) * 2002-11-08 2011-07-20 Ablynx N.V. Camelidae antibodies for sublingual administration
US20090005257A1 (en) * 2003-05-14 2009-01-01 Jespers Laurent S Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire
SI1639011T1 (sl) * 2003-06-30 2009-04-30 Domantis Ltd Pegilirana protitelesa z enojno domeno (dAb)
CN1893925B (zh) * 2003-08-21 2011-04-27 利普泰克有限公司 树突细胞的体内靶向
US8921528B2 (en) * 2004-06-01 2014-12-30 Domantis Limited Bispecific fusion antibodies with enhanced serum half-life
CA2588892A1 (en) * 2004-12-02 2006-06-08 Dormantis Limited Anti-il-1r1 single domain antibodies and therapeutic uses
BRPI0518761A2 (pt) * 2004-12-02 2008-12-09 Domantis Ltd fusço de droga, conjugado de droga, Ácido nucleico recombinante, construÇço de Ácido nucleico, cÉlula hospedeira, mÉtodo para produzir uma fusço de droga, composiÇço farmacÊutica, droga, mÉtodo de tratamento e/ou prevenÇço de uma condiÇço em um paciente, mÉtodo de retardo ou prevenÇço de progressço de doenÇa, e, mÉtodo para diminuir a absorÇço de alimentos por um paciente
WO2006097689A2 (en) * 2005-03-18 2006-09-21 Domantis Limited Antibodies against candida antigens
TW200804425A (en) * 2005-12-06 2008-01-16 Domantis Ltd Ligands that have binding specificity for EGFR and/or VEGF and methods of use therefor
CA2632424A1 (en) * 2005-12-06 2007-06-14 Domantis Limited Bispecific ligands with binding specificity to cell surface targets and methods of use therefor
TW200804593A (en) * 2006-01-24 2008-01-16 Domantis Ltd Fusion proteins that contain natural junctions
WO2008039432A1 (en) * 2006-09-26 2008-04-03 Alexion Pharmaceuticals, Inc. Compositions and methods for enhancing an adjuvant
US20100143371A1 (en) * 2006-10-31 2010-06-10 Zhenping Zhu Intrabodies
CN101182539A (zh) * 2007-11-06 2008-05-21 浙江大学 Dc-sign启动子荧光素酶报告质粒的构建方法

Similar Documents

Publication Publication Date Title
JP6181145B2 (ja) 改善された特異性を有する新規免疫グロブリン結合タンパク質
JP2013509879A5 (enExample)
JP2015212284A5 (enExample)
JP2007197439A5 (enExample)
JP2005120106A5 (enExample)
JP2016052315A5 (enExample)
JP2013078329A5 (enExample)
JP2012095652A5 (enExample)
JP2016538240A5 (enExample)
JP2015524403A5 (enExample)
JP2009201525A5 (enExample)
WO2011112089A3 (en) Mutated rep encoding sequences for use in aav production
NZ610075A (en) Cxcr2 binding polypeptides
JP2012526530A5 (enExample)
JP2009527226A5 (enExample)
JP2009529509A5 (enExample)
FI3527070T3 (fi) Humanisoituja kevytketjuhiiriä
JP2010227116A5 (enExample)
JP2012525819A5 (enExample)
JP2015527366A5 (enExample)
JP2015537044A5 (enExample)
JP2011521653A5 (enExample)
JP2012507994A5 (enExample)
WO2008049106A3 (en) Process for preparing unaggregated antibody fc domains
HRP20221142T1 (hr) Modificirana igg protutijela koja se vežu na transformirajući faktor rasta beta1 s visokim afinitetom, avidnošću i specifičnošću